📰 3 sources covering this story

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial

First covered 7 hrs ago · latest take 46 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial
‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial
The drug is based on the same messenger RNA (mRNA) technology behind Covid-19 vaccines.
Reason
Reason1 hrs ago
Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers
Pharmaceutical companies Moderna and Merck announced today the highly promising results of their anti-cancer mRNA vaccine Phase 3 clinical trial targeting later-stage melanoma skin cancers. Researchers sequenced the DNA from each patient's tumors to create personalized vaccines that, when injected, rev up the immune sy
The Independent
The Independent🏁 first to report7 hrs ago
Skin cancer breakthrough after experimental mRNA drug found to prevent disease returning
More than 8,500 Americans are expected to die of melanoma this year
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →